Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis

BACKGROUND: Primary membranous nephropathy (MN), sometimes referred to as idiopathic membranous nephropathy (IMN), is a kind of MN whose pathogenesis is yet unclear. According to research reports, the incidence of IMN is about 9.8–26.8%, and it is on the rise. METHODS: The computer retrieves eight d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Huijuan, Shen, Jun, Sun, Jieqiong, Sun, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581616/
https://www.ncbi.nlm.nih.gov/pubmed/36276580
http://dx.doi.org/10.1155/2022/5393797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581616/
https://www.ncbi.nlm.nih.gov/pubmed/36276580
http://dx.doi.org/10.1155/2022/5393797

Ejemplares similares